Posts by: Iqra Mumal, PhD

Levels of endocan, an indicator of inflammation, can be used as a predictive biomarker for the involvement of the cardiovascular system and the development of atherosclerosis in patients with ... Read more

May 15, 2018May 15, 2018

Newly Established Registry Sheds Light on Treatment, Features of Sarcoidosis-linked PH

A newly established registry for patients with sarcoidosis associated with pulmonary hypertension sheds light on characteristics and treatment patterns that can be used for future randomized clinical trials, according ... Read more

May 8, 2018May 8, 2018

High Blood Calcium Levels, Scarring on Scalp, Kidney Failure Rare in Sarcoidosis Cases, Report Says

In rare cases of sarcoidosis, patients may have high blood calcium levels (hypercalcemia), scarring on the scalp, and kidney failure, according to a new report. The case report, titled “Symptomatic ... Read more

April 17, 2018April 17, 2018

Sarcoidosis Research Foundation Awards Travel Grants to Top Investigators Presenting at Meeting

The Foundation for Sarcoidosis Research (FSR) has invested $1 million in its new Clinical and Research Fellowship Program. It also gave travel awards to the first authors of the top ... Read more

December 7, 2017December 7, 2017

Case Report Suggests Radiotherapy as Treatment for Patients with Bone Involvement Sarcoidosis

Radiotherapy may be useful for the control of sarcoidosis associated with bone involvement, according to a recent case report. “Emergency Radiotherapy for Spinal Cord Compression” was published in the ... Read more

November 30, 2017November 30, 2017

Remicade Treatment Appears to Benefit Patients with Neurosarcoidosis, Study Finds

Treatment with Remicade (infliximab) in neurosarcoidosis patients is associated with favorable imaging and clinical treatment responses, new research shows. The study, “Infliximab for the treatment of CNS sarcoidosis,” was ... Read more

October 3, 2017October 3, 2017

TNF Antagonists Are Effective at Treating Sarcoidosis, but Adverse Events Are a Concern

Tumor necrosis factor (TNF) antagonists are effective therapies in a significant proportion of patients with severe and refractory sarcoidosis, a new study shows. However, they also are associated with ... Read more

June 21, 2017June 23, 2017

High Prevalence of Fatigue and Excessive Daytime Sleepiness Found in Sarcoidosis Patients

A new study reports that 16.5% of sarcoidosis patients experience EDS (excessive daytime sleepiness), 16.4% experience severe fatigue, and 6.3% of patients report both symptoms. The study titled, “Fatigue ... Read more